Skip to main content

Table 1 Characteristics of patients included in the immunohistochemistry study

From: Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease

Variable AD patients (N=56)
Age at death (years)
 Median [IQR] 80.0 [72.0-87.0]
 Range 56.0, 96.0
Sex – n of patients (%)
 Female 37 (66.1)
 Male 19 (33.9)
Post mortem interval
 Median [IQR] 26.5 [19.0-34.0]
 Range 3.0, 96.0
 Missing (n) 4
Braak Stage – n of patients (%)
 IV 1 (1.8)
 V-VI 55 (98.2)
Thal – n of patients (%)
 2 2 (3.57)
 3 5 (8.93)
 4 16 (28.57)
 5 33 (58.93)